Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bellicum Pharmaceuticals ...

    NASDAQ: BLCM · Real-Time Price · USD
    0.07
    -0.01 (-12.61%)
    At close: Mar 04, 2024, 8:59 PM

    Bellicum Pharmaceuticals Statistics

    Share Statistics

    Bellicum Pharmaceuticals has 10.41M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 10.41M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 6.78M

    Failed to Deliver (FTD) Shares

    n/a
    		 4,448

    FTD / Avg. Volume

    n/a
    		 15.56%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.89 and the forward PE ratio is null. Bellicum Pharmaceuticals's PEG ratio is 0.37.

    PE Ratio

    n/a
    		 -0.89

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 14.8

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 11.02

    P/FCF Ratio

    n/a
    		 -0.86

    PEG Ratio

    n/a
    		 0.37
    Financial Ratio History

    Enterprise Valuation

    Bellicum Pharmaceuticals has an Enterprise Value (EV) of 359.34K.

    EV / Sales

    n/a
    		 0.24

    EV / EBITDA

    n/a
    		 -0.01

    EV / EBIT

    n/a
    		 -0.01

    EV / FCF

    n/a
    		 -0.01

    Financial Position

    The company has a current ratio of 6.31, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 6.31

    Quick Ratio

    n/a
    		 6.36

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -586543.48

    Financial Efficiency

    Return on Equity is -1239.35% and Return on Invested Capital is -1339.11%.

    Return on Equity

    n/a
    		 -1239.35%

    Return on Assets

    n/a
    		 -104.83%

    Return on Invested Capital

    n/a
    		 -1339.11%

    Revenue Per Employee

    n/a
    		 $115,384.62

    Profits Per Employee

    n/a
    		 $-1,921,000

    Employee Count

    n/a
    		 13

    Asset Turnover

    n/a
    		 0.06

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 2K

    Effective Tax Rate

    n/a
    		 -0.01%

    Stock Price Statistics

    The stock price has increased by -6.35% in the last 52 weeks. The beta is 1.38, so Bellicum Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.38

    52-Week Price Change

    n/a
    		 -6.35%

    50-Day Moving Average

    n/a
    		 0.11

    200-Day Moving Average

    n/a
    		 0.29

    Relative Strength Index (RSI)

    n/a
    		 40.84

    Average Volume (20 Days)

    n/a
    		 28,581

    Income Statement

    In the last 12 months, Bellicum Pharmaceuticals had revenue of 1.5M and earned -24.97M in profits. Earnings per share was -0.81.

    Revenue

    n/a
    		 1.5M

    Gross Profit

    n/a
    		 1.5M

    Operating Income

    n/a
    		 -26.98M

    Net Income

    n/a
    		 -24.97M

    EBITDA

    n/a
    		 -26.98M

    EBIT

    n/a
    		 -24.97M

    Earnings Per Share (EPS)

    n/a
    		 -0.81
    Full Income Statement

    Balance Sheet

    The company has 21.84M in cash and 0 in debt, giving a net cash position of 21.84M.

    Cash & Cash Equivalents

    n/a
    		 21.84M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -575.42M

    Total Assets

    n/a
    		 6.85M

    Working Capital

    n/a
    		 4.6M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -25.78M and capital expenditures -21K, giving a free cash flow of -25.8M.

    Operating Cash Flow

    n/a
    		 -25.78M

    Capital Expenditures

    n/a
    		 -21K

    Free Cash Flow

    n/a
    		 -25.8M

    FCF Per Share

    n/a
    		 -0.84
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -1798.73% and -1664.87%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -1798.73%

    Pretax Margin

    n/a
    		 -1664.73%

    Profit Margin

    n/a
    		 -1664.87%

    EBITDA Margin

    n/a
    		 -1798.73%

    EBIT Margin

    n/a
    		 -1798.73%

    FCF Margin

    n/a
    		 -1720.27%

    Dividends & Yields

    BLCM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -112.51%

    FCF Yield

    n/a
    		 -116.25%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BLCM.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 6, 2020. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Feb 6, 2020

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -129.69

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist